The reimbursement for expensive medicines: stakeholder perspectives on the SMA medicine nusinersen and the Dutch Coverage Lock policy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6963
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The reimbursement for expensive medicines: stakeholder perspectives on the SMA medicine nusinersen and the Dutch Coverage Lock policy ; volume:22 ; number:1 ; day:4 ; month:11 ; year:2022 ; pages:1-9 ; date:12.2022
BMC health services research ; 22, Heft 1 (4.11.2022), 1-9, 12.2022
- Creator
-
Scheijmans, Féline E. V.
Zomers, Margot L.
Fadaei, Sina
Onrust, Marthe R.
Graaf, Rieke van der
Delden, Johannes J. M. van
Pol, W. Ludo van der
Thiel, Ghislaine J. M. W. van
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12913-022-08690-z
- URN
-
urn:nbn:de:101:1-2023011921195115286110
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Scheijmans, Féline E. V.
- Zomers, Margot L.
- Fadaei, Sina
- Onrust, Marthe R.
- Graaf, Rieke van der
- Delden, Johannes J. M. van
- Pol, W. Ludo van der
- Thiel, Ghislaine J. M. W. van
- SpringerLink (Online service)
Other Objects (12)
Medicines and the media: news reports of medicines recommended for government reimbursement in Australia
Impact of delisting OTC medicines from reimbursement list
Evidence for the effectiveness of anti-hypertensive medicines included on the Chinese National Reimbursement Drug List
Patient organisations and the reimbursement process for medicines: an exploratory study in eight European countries
Approval, reimbursement and pricing of high-cost cancer medicines in Australia
Expensive living: The Greek experience under the Euro
Expensive living: the Greek experience under the euro
Expensive habits
Expensive luxury
Reimbursement categories as a way of allocating measures and monitoring expenditures on medicines
Understanding the trends in international agreements on pricing and reimbursement for newly marketed medicines and their implications for access to medicines: a computational text analysis
The Rape of the Lock
Medicines and the media: news reports of medicines recommended for government reimbursement in Australia
Impact of delisting OTC medicines from reimbursement list
Evidence for the effectiveness of anti-hypertensive medicines included on the Chinese National Reimbursement Drug List
Patient organisations and the reimbursement process for medicines: an exploratory study in eight European countries
Approval, reimbursement and pricing of high-cost cancer medicines in Australia
Expensive living: The Greek experience under the Euro
Expensive living: the Greek experience under the euro
Expensive habits
Expensive luxury
Reimbursement categories as a way of allocating measures and monitoring expenditures on medicines
Understanding the trends in international agreements on pricing and reimbursement for newly marketed medicines and their implications for access to medicines: a computational text analysis
The Rape of the Lock
Medicines and the media: news reports of medicines recommended for government reimbursement in Australia
Impact of delisting OTC medicines from reimbursement list
Evidence for the effectiveness of anti-hypertensive medicines included on the Chinese National Reimbursement Drug List
Patient organisations and the reimbursement process for medicines: an exploratory study in eight European countries
Approval, reimbursement and pricing of high-cost cancer medicines in Australia
Expensive living: The Greek experience under the Euro
Expensive living: the Greek experience under the euro
Expensive habits
Expensive luxury
Reimbursement categories as a way of allocating measures and monitoring expenditures on medicines
Understanding the trends in international agreements on pricing and reimbursement for newly marketed medicines and their implications for access to medicines: a computational text analysis